The interaction of CYP1A1 (Msp1) with mt/mt genotype and GSTM1 null genotype could enhance the risk of lung cancer, and the OR of which were a little higher than the other two CYP1A1 (Msp1) genotypes with GSTM1 null. This evidence concerns the gene ATAD1 and lung cancer.